Table 4 Univariate analysis, primary endpoint: 30-days mortality

Age > 70 y

17

37.8

28

6.4

1.04

(0.56 – 1.95)

0.875

Female

13

28.9

32

5.9

1.55

(0.79 – 3.03)

0.192

HT

35

79.5

9

9.9

0.55

(0.26 – 1.22)

0.163

pulmonal. HT

7

16.3

36

5.5

4.44

(1.81 – 10.89)

0.003

HLP

21

47.7

23

13.4

0.27

(0.15 – 0.51)

<0,001

Diab. mellitus

18

40.0

27

6.1

1.18

(0.64 – 2.19)

0.632

BMI > 30

13

28.9

32

6.5

1.01

(0.52 – 1.96)

1.000

AF

15

34.1

29

4.8

4.60

(2.34 – 9.03)

<0,001

3 V–CAD

32

71.1

13

10.1

0.54

(0.27 – 1.05)

0.074

LMS

20

44.4

25

5.4

1.63

(0.89 – 3.00)

0.141

COPD

9

20.0

36

5.8

2.13

(0.99 – 4.62)

0.080

PAD

15

33.3

30

5.2

2.62

(1.36 – 5.03)

0.007

Smoker

22

50.0

22

5.7

1.27

(0.59 – 2.33)

0.531

Crea >2

6

14.0

37

5.7

4.32

(1.66 – 11.24)

0.007

Renal insuff. preop. Crea <2

23

51.1

22

4.7

2.25

(1.23 – 4.14)

0.013

CVA

6

13.6

38

6.6

0.79

(0.33 – 1.91)

0.333

Beta–blocker

27

62.8

16

11.8

0.38

(0.20 – 0.73)

0.005

Statin

22

51.2

21

13.6

0.27

(0.14 – 0.51)

<0,001

Antiplatelet

29

67.4

14

3.6

2.90

(1.50 – 5.59)

<0,001

EF < 40 %

30

66.7

15

3.1

5.36

(2.82 – 10.21)

<0,001

EF 40–50 %

8

17.8

37

7.0

0.70

(0.32 – 1.53)

0.466

EF >50 %

7

15.6

38

10.4

0.19

(0.08 – 0.43)

<0,001

Euroscore > =6

40

95.2

2

0.6

16.98

(4.07 – 70.85)

<0,001

IABP preop.

6

13.3

39

5.9

3.68

(1.43 – 9.45)

0.013

NYHA III + IV

34

75.6

11

3.3

2.96

(1.48 – 5.94)

0.002

Emergent CABG

34

75.6

11

2.5

6.43

(3.15 – 12.76)

<0,001

preop. myocardial infarction

22

50.0

22

4.4

3.26

(1.76 – 6.06)

<0,001

<3d

27

65.9

14

3.2

4.41

(2.26 – 8.60)

<0,001

<24 h

26

63.4

15

3.1

5.79

(2.99 – 11.24)

<0,001

OP–time after 08.00 pm

6

13.3

39

6.2

1.57

(0.64 – 3.86)

0.292

ICC cardioplegia

10

23.8

32

6.3

0.89

(0.43 – 1.86)

0.857

IWC cardioplegia

31

73.8

11

6.2

0.99

(0.48 – 2.00)

1.000

AoX < 80 min

37

88.1

5

35.7

0.11

(0.03 0.33)

0.001

AoX > 60 min

6

14.3

36

5.9

1.39

(0.57 – 3.43)

0.444

AoX >45 min

13

31.0

29

6.3

0.91

(0.46 – 1.78)

0.866

CPB >180 min

10

22.7

34

5.0

37.82

(12.25 116.80)

<0,001

CPB > 120 min

20

45.5

24

3.9

9.36

(4.85 – 18.04)

<0,001

OP–time > 180 min

33

73.3

12

3.9

2.47

(1.25 – 4.88)

0.008

Reperfusion time > 60 min

17

39.5

26

4.1

13.40

(6.57 – 27.34)

<0,001

Hemofiltration

27

60.0

IS

3.2

8.54

(4.53 – 16.10)

<0,001

PDI (Corotrop)

24

54.5

20

2.9

3.71

(2.00 – 6.90)

<0,001

PMI

36

80.0

9

1.7

14.71

(6.92 – 31.26)

<0,001

ICU > 3d

29

69.0

13

3.3

3.28

(1.67 – 6.43)

<0,001

ICU > 5d

19

45.2

23

4.6

2.52

(8.83 – 34.82)

0.006

ICU > 7d

16

38.1

26

4.8

2.59

(1.35 – 4.97)

0.005

ICU > 10d

12

28.6

30

5.1

3.13

(1.53 – 6.38)

0.003

Hospital stay > 15 d

10

22.7

34

6.3

1.07

(0.51 – 2.21)

0.851

Ventilation time >48 h

23

62.2

14

2.6

11.23

(5.54 – 22.73)

<0,001

IABP preop.

27

60.0

18

2.9

15.91

(8.25 – 30.67)

<0,001

ECMO

15

33.3

30

4.4

107.83

(29.61 – 392.72)

<0,001

Blood transfusion

43

100.0

0

0.0

0.92

(0.90 – 0.94)

0.068

RBC Unit >5

31

68.9

14

2.7

8.48

(4.39 – 16.39)

<0,001

Total blood loss >1l

19

65.6

10

2.7

2.62

(1.20 – 5.73)

0.020

Total blood loss >2l

12

41.4

17

3.0

6.17

(2.82 – 13.52)

<0,001

Dialysis

12

26.7

33

5.0

8.08

(3.77 – 12.30)

<0,001

Inotropie support >48 h

26

89.7

3

0.8

12.19

(3.65 40.70)

<0,001

ACT > 150 sec

10

41.7

14

3.1

4.33

(1.85 – 10.10)

<0,001

Pneumonia

10

22.7

34

5.1

12.39

(5.19 – 29.62)

<0,001

Wound infection

3

6.8

41

6.5

0.77

(0.23 – 2.57)

1.000

Operative re–exploration

13

29.5

31

4.8

6.91

(3.34 – 14.31)

<0,001